PFIZER

Pfizer Share Price

₹5,433.00 +22 (0.41%)

15 Jul, 2025 12:02

SIP TrendupStart SIP in PFIZER

Start SIP

Performance

  • Low
  • ₹5,407
  • High
  • ₹5,496
  • 52 Week Low
  • ₹3,701
  • 52 Week High
  • ₹6,451
  • Open Price₹5,448
  • Previous Close₹5,411
  • Volume14,487

Investment Returns

  • Over 1 Month -7.71%
  • Over 3 Month + 33.06%
  • Over 6 Month + 6.72%
  • Over 1 Year + 11.79%
SIP Lightning

Smart Investing Starts Here Start SIP with Pfizer for Steady Growth!

Invest Now

Pfizer Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 32.4
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 24,855
  • P/B Ratio
  • 6.6
  • Average True Range
  • 148.4
  • EPS
  • 140.08
  • Dividend Yield
  • 3.7
  • MACD Signal
  • 99.28
  • RSI
  • 40.47
  • MFI
  • 67.18

Pfizer Financials

Pfizer Technicals

EMA & SMA

Current Price
₹5,433.00
+ 22 (0.41%)
pointer
  • stock-down_img
  • Bearish Moving Average 9
  • stock-up_img
  • Bullish Moving Average 7
  • 20 Day
  • ₹5,627.23
  • 50 Day
  • ₹5,368.47
  • 100 Day
  • ₹5,090.19
  • 200 Day
  • ₹4,948.68

Resistance and Support

5437 Pivot Speed
  • R3 5,616.00
  • R2 5,565.00
  • R1 5,488.00
  • S1 5,360.00
  • S2 5,309.00
  • S3 5,232.00

What's your outlook on Pfizer?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Pfizer is a global pharmaceutical company offering innovative medicines and vaccines across therapeutic areas, including oncology, cardiology, and infectious diseases. It operates in India, focusing on enhancing patient access to advanced treatments and healthcare solutions.

Pfizer (Nse) has an operating revenue of Rs. 2,281.35 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 45% is great, ROE of 18% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 72 which is a FAIR score but needs to improve its earnings, a RS Rating of 74 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 52 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Pfizer Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-19 Audited Results & Special Dividend
2025-01-31 Quarterly Results
2024-10-28 Quarterly Results
2024-07-29 Quarterly Results
2024-05-17 Audited Results & Final Dividend
Date Purpose Remarks
2025-07-09 FINAL Rs.35.00 per share(350%)Final Dividend
2025-07-09 SPECIAL Rs.130.00 per share(1300%)Special Dividend
2024-08-21 FINAL Rs.35.00 per share(350%)Final Dividend
2023-08-11 FINAL Rs.35.00 per share(350%)Final Dividend
2023-08-11 SPECIAL Rs.5.00 per share(50%)Special Dividend
View More

Pfizer F&O

Pfizer Shareholding Pattern

63.92%
11.59%
5.43%
2.18%
0.02%
12.34%
4.52%

About Pfizer

  • NSE Symbol
  • PFIZER
  • BSE Symbol
  • 500680
  • Managing Director
  • Ms. Meenakshi Nevatia
  • ISIN
  • INE182A01018

Similar Stocks to Pfizer

Pfizer FAQs

Pfizer share price is ₹5,433 As on 15 July, 2025 | 11:48

The Market Cap of Pfizer is ₹24854.7 Cr As on 15 July, 2025 | 11:48

The P/E ratio of Pfizer is 32.4 As on 15 July, 2025 | 11:48

The PB ratio of Pfizer is 6.6 As on 15 July, 2025 | 11:48

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23